(Q33361624)

26 July 2017

title

A phase II study of UFT and Leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer (English)

1 reference

26 July 2017

1 reference

2

Bengt Glimelius

1 reference

26 July 2017

Niels Gyldenkerne

1

1 reference

26 July 2017

Jan Erik Frödin

3

1 reference

26 July 2017

Mogens Kjaer

4

1 reference

26 July 2017

Per Pfeiffer

5

1 reference

26 July 2017

Flemming Hansen

6

1 reference

26 July 2017

Nina Keldsen

7

1 reference

26 July 2017

Erik Sandberg

8

1 reference

26 July 2017

Anders Jakobsen

9

1 reference

26 July 2017

language of work or name

1 reference

1 January 2004

1 reference

26 July 2017

1 reference

26 July 2017

volume

43

1 reference

26 July 2017

issue

3

1 reference

26 July 2017

page(s)

276-279

1 reference

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860410028655

Dual modulation of UFT with leucovorin and hydroxyurea in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860410028655

A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860410028655

Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860410028655

5-Fluorouracil and mitomycin-C in colorectal cancer: unacceptable conclusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860410028655

10.1080/02841860410028655

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference